Clinical Trial Update: Vitamin D3 (Vit D3) Supplementation and T Cell Immunomodulation in Patients With Newly Diagnosed Operative Invasive Ductal Breast Carcinoma [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating Vitamin D3 supplementation and T cell immunomodulation in patients with newly diagnosed operable invasive ductal breast carcinoma (Stag…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Invasive Ductal Carcinoma of the Breast

Drugs mentioned

• Vitamin D3 (Cholecalciferol)

Snippet

Sponsor: Medical University of South Carolina | Conditions: Newly Diagnosed Operative Invasive Ductal Breast Carcinoma Stage I-II | Phase 1 | Status: TERMINATED